Sanofi Pasteur Inc. was awarded a single-award indefinite delivery contract by the Department of Health and Human Services Centers for Disease Control and Prevention potentially valued at $64 million. The contract provides for the delivery of seasonal influenza vaccines to support public health programs as outlined in Section 317(j) of the Public Health Service Act. Performance will occur at the prime contractor's manufacturing facility in Swiftwater, Pennsylvania or other locations as needed to...
This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, aims to procure products and services related to the FLU 2009 Vaccine Formal Agreement (FLU 2009 VFA) program. The single-award contract, which has a ceiling value of $18,843,626.15 and a period of performance ending on February 28, 2010, was awarded to GlaxoSmithKline Holdings (Americas) Inc. on April 24, 2009. The contract does not...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to MedImmune, LLC, a for-profit organization. The single-award IDC has a ceiling value of $373,407,823 and a period of performance ending on February 28, 2011. The contract aims to procure flu vaccine products and related services as part of the CDC's Vaccine for Children (VFC) program in support of the 2010 flu season. The...
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $5.87 billion Indefinite Delivery Indefinite Quantity (IDIQ) contract to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to supply medical countermeasures (MCMs) such as vaccines and adjuvants for pandemic preparedness and response. This IDIQ contract serves as the vehicle for issuing multiple delivery orders to Sanofi Pasteur over a...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $640,309,577 multiple-award contract, identified as VFA 2009, has an ultimate completion date of June 30, 2010. Under this IDC, Sanofi Pasteur Inc. is the prime contractor responsible for providing a range of vaccine products and services to support various federal...
The Defense Logistics Agency Troop Support Medical awarded Sanofi Pasteur Inc. a single award, indefinite delivery contract with a potential value of $567,566.40 to provide 850,886,1267 units of influenza virus vaccine. A firm fixed price delivery order against this contract specifies performance at Sanofi Pasteur Inc.'s Swiftwater, Pennsylvania facility from February 9, 2022 through May 13, 2022. The originating pre-solicitation sought sources capable of providing 60,000 doses of Southern...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc. as the prime contractor. The contract has a ceiling value of $1,219,916,713.60 and a period of performance through January 31, 2011. Under this IDC, Sanofi Pasteur Inc. is providing a range of vaccine products and services to support disease prevention and maintain public health preparedness for federal agencies including the Department...
This indefinite delivery contract, awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), has a ceiling value of $4,687,707,199. The purpose is to provide medical countermeasures such as vaccines and adjuvants for pandemic preparedness and response or in response to a public health emergency designated by HHS. The prime contractor is Glaxosmithkline, LLC, a pharmaceutical company that...
This IDV contract, awarded by the Defense Logistics Agency Troop Support, is for the supply of approximately 3.35 million doses of injectable influenza vaccine for the 2025-2026 flu season. The contract is a single-award indefinite quantity vehicle with a ceiling value of $25,058,634.80 and a period of performance through February 13, 2026. The prime contractor is Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The...
This single award IDV from the Department of Health and Human Services Centers for Disease Control and Prevention to Seqirus USA Inc. has a potential value of $129,537,700 to procure adult flu vaccines through February 2022. The originating solicitation sought to award one or more IDVs for the purchase of influenza vaccines for individuals aged 19 years and older, with a minimum order of 100 doses and maximum of 20 million doses to support adult immunization programs under Section 317(j) of...